YOUR BUSINESS AUTHORITY
Springfield, MO
A drug that's said to be the biggest advance in treating depression since the introduction of Prozac in 1987 is nearing approval by the U.S. Food and Drug Administration.
Johnson & Johnson’s esketamine, a close chemical cousin of the anesthetic ketamine, on Thursday was recommended by a panel of outside experts.
The fast-acting antidepressant is administered through a nasal spray.
Read more from Bloomberg.
A safe room and classroom addition at Willard Central Elementary School will be used by the music, arts and athletic programs for a district that had 4,536 students last year, according to Missouri Department of Elementary and Secondary Education figures, but school officials say enrollment is projected to grow.